Drug Interaction Report

Sertraline and Abciximab: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Sertraline

No brand names on record
+

Abciximab

No brand names on record
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 532 documented Sertraline interactions, 477 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Sertraline and abciximab both reduce platelet function, so combining them can increase bleeding risk; keep taking both as prescribed and report any unusual bleeding or bruising to your care team.

Taking sertraline with abciximab can raise your chance of bleeding. Sertraline is an antidepressant, and one of its lesser-known effects is that it makes your platelets (the cells that help you form clots) a little less sticky. Abciximab is a strong blood thinner given in the hospital that also blocks platelets from clumping. Put together, they work in the same direction, so bruising or bleeding can happen more easily.

You might notice things like nosebleeds, easy bruising, or tiny red spots on the skin. This is manageable. Your care team knows how to watch for this, and they can keep a close eye on you while you are on both. Let them know right away if you notice unusual bleeding or bruising.

Effect: Additive antiplatelet/hemostatic impairment, increasing bleeding risk. Neither agent is a prodrug; this is a pharmacodynamic (not metabolic) interaction.

  • Mechanism: Sertraline depletes platelet serotonin (via serotonin reuptake inhibition in platelets), impairing serotonin-mediated aggregation; abciximab is a GPIIb/IIIa inhibitor. Effects are additive on hemostasis.
  • Direction/magnitude: Increased bleeding risk; magnitude not quantified.
  • Onset: Unspecified.
  • Evidence: Theoretical, supported by case-control/cohort data with SSRI plus antiplatelet combinations.
  • Management: Monitor for epistaxis, ecchymosis, hematoma, petechiae, and overt hemorrhage; counsel patient. Given abciximab is acute/procedural, weigh bleeding risk in that setting.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

An increased risk of bleeding

Interaction Deep Dive

Care should be taken when an SSRI is given together with an antiplatelet agent, since the combination may heighten the likelihood of bleeding events32. Using sertraline alongside an antiplatelet can amplify bleeding risk, a phenomenon possibly attributable to sertraline's influence on platelet serotonin release. Data from case-control and cohort studies have linked the joint use of selective serotonin and norepinephrine reuptake inhibitors (sertraline among them) with antiplatelet agents to a greater bleeding risk. The bleeding events documented range from epistaxis, ecchymosis, hematoma, and petechiae to hemorrhages that are life-threatening. During concurrent administration of sertraline and an antiplatelet agent, observe the patient for indications of heightened bleeding and advise patients regarding the elevated bleeding risk 1.

Why it happens (mechanism)

Release of serotonin by platelets; additive effects on hemostasis

How to manage this interaction

Keep taking both exactly as prescribed unless your care team tells you otherwise. Abciximab is given in a hospital or procedure setting, so your team is already watching you closely.

  • Your team may monitor you more closely for bleeding while you are on both.
  • Watch for and report nosebleeds, easy bruising, tiny red skin spots (petechiae), blood in urine or stool, or any bleeding that will not stop.
  • Tell your pharmacist or prescriber that you take sertraline, especially before any procedure.
  • Do not start or stop either medication on your own; raise any concerns with your care team.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

3 reports — tap to read

a) A retrospective study involving patients older than 50 years diagnosed with acute myocardial infarction (N=27,058) found that using an SSRI together with any antiplatelet therapy significantly raised bleeding risk by 1.42-fold relative to aspirin alone. The combination of aspirin, clopidogrel, and an SSRI significantly elevated the risk by 2.35-fold versus aspirin alone and by 1.57-fold versus combined clopidogrel and aspirin therapy 2.

b) A systematic review and meta-analysis covering 22 observational studies found that SSRI use was linked to a significant 1.55-fold rise in the risk of upper gastrointestinal bleeding (UGIB). Using SSRIs together with antiplatelet drugs was linked to a 2.48-fold increase in UGIB risk (3 studies) 3.

c) Case reports and epidemiological studies (case-control and cohort designs) have shown a link between the use of agents that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. According to data from published observational studies, exposure to SSRIs, especially during the month before delivery, has been linked to a less than 2-fold increase in the risk of postpartum hemorrhage. Bleeding events associated with SSRIs and SNRIs have spanned from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.

Common questions

Can I take Sertraline and Abciximab together?

Sertraline and abciximab both reduce platelet function, so combining them can increase bleeding risk; keep taking both as prescribed and report any unusual bleeding or bruising to your care team. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Sertraline and Abciximab interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Sertraline and Abciximab interaction managed?

Keep taking both exactly as prescribed unless your care team tells you otherwise. Abciximab is given in a hospital or procedure setting, so your team is already watching you closely. Your team may monitor you more closely for bleeding while you are on both. Watch for and report nosebleeds, easy bruising, tiny red skin spots (petechiae), blood in urine or stool, or any bleeding that will not stop.… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Sertraline or Abciximab need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (3)

  1. Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
  2. Labos C, Dasgupta K, Nedjar H, et al: Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ 2011; 183(16):1835-1843. PubMed
  3. Jiang HY, Chen HZ, Hu XJ, et al: Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2015; 13(1):42-50. PubMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.